Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Preeti}} | {{CMG}}; {{AE}} {{Preeti}} | ||
{| | {| | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | |||
! rowspan="4" |Category | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! rowspan="4" |Disease | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | ||
! rowspan="4" |Etiology | ! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | ||
! colspan="2" rowspan="3" |Mechanism | ! colspan="12" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations | ||
! colspan="12" rowspan="2" |Clinical manifestations | ! colspan="11" align="center" style="background:#4479BA; color: #FFFFFF;" + |Paraclinical findings | ||
! colspan="11" |Paraclinical findings | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | ||
! rowspan="4" | | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ||
! rowspan="4" |Associated findings | |||
|- | |- | ||
! colspan="10" |Lab findings | ! colspan="10" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Demography | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ||
! rowspan="2" |History | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History | ||
! colspan="4" |Symptoms | ! colspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms | ||
! colspan="6" |Signs | ! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs | ||
! colspan="3" |CBC | ! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |CBC | ||
! rowspan="2" |PBS | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |PBS | ||
! rowspan="2" |LFT | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |LFT | ||
! rowspan="2" |PT/PTT | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |PT/PTT | ||
! rowspan="2" |Immunochemistry | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | ||
! rowspan="2" |Blood work | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Blood work | ||
! rowspan="2" |Histopathology | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | ||
! rowspan="2" |Other | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
! rowspan="2" |Imaging | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | ||
|- | |- | ||
!Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ||
!Acquired | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Acquired | ||
!Constitutional | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constitutional symptoms | ||
!Rash | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Rash | ||
!Abdominal pain | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Abdominal pain | ||
!Diarrhea | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Diarrhea | ||
!V/S | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |V/S | ||
!Mass | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mass | ||
!LAP | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |LAP | ||
! | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hepatosplenomegaly | ||
!Arthritis | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Arthritis | ||
!Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
!WBC | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |WBC | ||
!Hb | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hb | ||
!Plt | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ||
|- | |- | ||
! colspan="30" align="center" style="background:#4479BA; color: #FFFFFF;" + |HL | |||
|- | |- | ||
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ||
|Hodgkin's Lymphoma | ! align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ||
| | | | ||
| | | | ||
Line 80: | Line 79: | ||
| | | | ||
|- | |- | ||
! colspan="30" align="center" style="background:#4479BA; color: #FFFFFF;" + |NHL | |||
|- | |- | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | |||
|Acute Lymphobalstic lymphoma | ! align="center" style="background:#DCDCDC;" + |Acute Lymphobalstic lymphoma | ||
| | | | ||
* Precursor B-cell Lymphoma | * Precursor B-cell Lymphoma |
Revision as of 19:46, 28 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | |||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Blood work | Histopathology | Other | Imaging | |||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Acute Lymphobalstic lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
||||||||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic:
|
|
||||||||||||||||||||
Burkitt’s lymphoma |
|
||||||||||||||||||||||||||||
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma |
|
||||||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
|
CBC
|
|
||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Plasma cell myeloma | |||||||||||||||||||||||||||||
Chronic lymphocytic leukemia / small lymphocytic lymphoma | |||||||||||||||||||||||||||||
Monoclonal B-cell lymphocytosis | |||||||||||||||||||||||||||||
B-cell prolymphocytic leukemia | |||||||||||||||||||||||||||||
Waldenström's macroglubulinemia | |||||||||||||||||||||||||||||
Monoclonal gammopathy of undetermined significance (MGUS) | |||||||||||||||||||||||||||||
Heavy chain disease | |||||||||||||||||||||||||||||
Solitary plasmacytoma of bone | |||||||||||||||||||||||||||||
Extraosseous plasmacytoma | |||||||||||||||||||||||||||||
Monoclonal immunoglobulin deposition diseases | |||||||||||||||||||||||||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | |||||||||||||||||||||||||||||
Large B-cell lymphoma with IRF4 rearrangement | |||||||||||||||||||||||||||||
Primary cutaneous follicle center lymphoma | |||||||||||||||||||||||||||||
T-cell/histiocyte-rich large B-cell lymphoma | |||||||||||||||||||||||||||||
Lymphomatoid granulomatosis | |||||||||||||||||||||||||||||
Primary mediastinal (thymic) large B-cell lymphoma | |||||||||||||||||||||||||||||
Intravascular large B-cell lymphoma | |||||||||||||||||||||||||||||
ALK1 large B-cell lymphoma | |||||||||||||||||||||||||||||
Plasmablastic lymphoma | |||||||||||||||||||||||||||||
Primary effusion lymphoma | |||||||||||||||||||||||||||||
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | |||||||||||||||||||||||||||||
T cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
T-cell granular lymphocytic leukemia |
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following: |
|
|
|
||||||||||||||||||||||||
Subcutaneous panniculitis-like T-cell lymphoma |